Timothy Walbert

Timothy Walbert

Director/Board Member at SAGIMET BIOSCIENCES INC.

Net worth: 2 M $ as of 2026-05-30

59 year
Health Technology
Commercial Services
Consumer Services

Profile

Timothy P. Walbert is a businessperson who has been the head of 10 different companies and presently is Chairman, President & Chief Executive Officer of Horizon Therapeutics Plc, President & Chief Executive Officer of Horizon Therapeutics USA, Inc. (a subsidiary of Horizon Therapeutics Plc), Co-Chairman for MATTER Chicago, Chairman of Exicure, Inc. and President & Director at Viela Bio, Inc. He is also Member of The National Organization for Rare Disorders, Inc. and Member of Illinois Innovation Council and on the board of 9 other companies. In the past Mr. Walbert was Divisional VP & General Manager-Immunology at Abbott Laboratories, Manager-Market Integration at Merck & Co., Inc., Chairman for Zyla Life Sciences, Chairman, President & Chief Executive Officer for Horizon Pharma, Inc., President & Chief Executive Officer at Hyperion Therapeutics, Inc., President, Chief Executive Officer & Director at IDM Pharma, Inc., President & Chief Executive Officer for Horizon Therapeutics, Inc., Territory Manager at Wyeth Corp., Executive Vice President-Commercial Operations at NeoPharm, Inc. and Product Manager-Arthrotec & Cytotec at G.D. Searle & Co., Inc. Mr. Walbert received an undergraduate degree from Muhlenberg College.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-06-01 17,686 ( 0.01% ) 1 M $ 2026-05-30
2026-05-28 9,680 ( 0.02% ) 982 520 $ 2026-05-30
2026-04-16 2,200 ( 0% ) 16 038 $ 2026-05-30
2026-03-30 0 ( -.--% ) - $ 2026-05-30
2026-05-07 0 ( -.--% ) - $ 2026-05-30

Timothy Walbert active positions

CompaniesPositionStart
RAPTOR PHARMACEUTICAL CORP Director/Board Member 2016-10-24
SAGIMET BIOSCIENCES INC. Director/Board Member 2024-03-31
CENTURY THERAPEUTICS, INC. Director/Board Member 2022-09-30
MIRUM PHARMACEUTICALS, INC. Director/Board Member 2023-04-04
ODYSSEY THERAPEUTICS, INC. Director/Board Member 2024-05-31
BIOMARIN PHARMACEUTICAL INC. Director/Board Member 2025-02-23
CATALENT, INC. Director/Board Member -
Director/Board Member -
Corporate Officer/Principal -
░░░ ░░░░░░░░ ░░░░ ░░ ░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
░░░ ░░░░░░░░░░ ░░░░ ░░ ░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
░░░░ ░░░░░░░░░░░░░░░ ░░░░░░░░░░░ ░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ -
░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░ -

Former positions of Timothy Walbert

CompaniesPositionEnd
░░░░░░░ ░░░░░░░░░░░░ ░░░░░░ ░░░░░░░ ░░░░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░ ░░░░ ░░░░░░░░ ░░░░░░░░ ░░░░░░░░░░
See the detail of Timothy Walbert's experience

Training of Timothy Walbert

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

64

1st degree connections

45

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies45

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Process Industries

Consumer Services

Consumer Services

Commercial Services

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Commercial Services

Celebrex North America

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

The Wall Street Journal CEO Council

Illinois Innovation Council

Health Technology

Health Technology

Health Technology

Chicagonext

Electronic Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Illinois Biotechnology Innovation Organization

  1. Stock Market
  2. Insiders
  3. Timothy Walbert
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!